Refractive Results and Endothelial Cell Density After Eyecryl Phakic Intraocular Lens Implantation

INTRODUCTION[|]This study was an examination of the refractive results and complications encountered with implantation of the Eyecryl phakic intraocular lens (IOL) (Biotech Vision Care, Luzern, Switzerland).[¤]METHODS[|]IOL recipients with a follow-up period of at least 2 years were included the stu...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Ufuk Urdem [verfasserIn] Alper Agca [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2019

Schlagwörter:	cataract endothelial cells phakic intraocular lenses postoperative complications visual acuity.

Übergeordnetes Werk:	In: Beyoglu Eye Journal - KARE Publishing, 2020, 4(2019), 1, Seite 17-22
Übergeordnetes Werk:	volume:4 ; year:2019 ; number:1 ; pages:17-22

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc

DOI / URN:	10.14744/bej.2019.52824

Katalog-ID:	DOAJ004845854

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ004845854
003	DE-627
005	20230310183716.0
007	cr uuu---uuuuu
008	230225s2019 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.14744/bej.2019.52824 \|2 doi
035			\|a (DE-627)DOAJ004845854
035			\|a (DE-599)DOAJ2b027a394f7c49cb9bbe4f8833cff692
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
050		0	\|a RE1-994
100	0		\|a Ufuk Urdem \|e verfasserin \|4 aut
245	1	0	\|a Refractive Results and Endothelial Cell Density After Eyecryl Phakic Intraocular Lens Implantation
264		1	\|c 2019
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a INTRODUCTION[\|]This study was an examination of the refractive results and complications encountered with implantation of the Eyecryl phakic intraocular lens (IOL) (Biotech Vision Care, Luzern, Switzerland).[¤]METHODS[\|]IOL recipients with a follow-up period of at least 2 years were included the study. Uncorrected and corrected distance visual acuity (UDVA and CDVA, respectively), central endothelial cell density (ECD), and procedure-related complication data were recorded.[¤]RESULTS[\|]The study included 52 eyes from 26 patients. The efficacy index (postoperative UDVA/preoperative CDVA) was 1.32+-1.09 in the first year and 1.39+-1.03 in the second year. The safety index (postoperative CDVA/preoperative CDVA) was 1.69+-1.16 at the last follow-up. None of the patients lost 2 or more lines of CDVA. The mean ECD loss was –4.51+-9.69% at 1 year (p=0.005). There was no statistically significant ECD loss between the 1- and 2-year follow-up visits (p=0.794).[¤]DISCUSSION AND CONCLUSION[\|]The results of Eyecryl phakic IOL implantation were favorable in terms of efficacy and safety.[¤]
650		4	\|a cataract
650		4	\|a endothelial cells
650		4	\|a phakic intraocular lenses
650		4	\|a postoperative complications
650		4	\|a visual acuity.
653		0	\|a Ophthalmology
700	0		\|a Alper Agca \|e verfasserin \|4 aut
773	0	8	\|i In \|t Beyoglu Eye Journal \|d KARE Publishing, 2020 \|g 4(2019), 1, Seite 17-22 \|w (DE-627)1725122200 \|x 25870394 \|7 nnns
773	1	8	\|g volume:4 \|g year:2019 \|g number:1 \|g pages:17-22
856	4	0	\|u https://doi.org/10.14744/bej.2019.52824 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/2b027a394f7c49cb9bbe4f8833cff692 \|z kostenfrei
856	4	0	\|u https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-52824 \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/2587-0394 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 4 \|j 2019 \|e 1 \|h 17-22

Indexfelder

author_variant	u u uu a a aa
matchkey_str	article:25870394:2019----::ercieeutadnohlacldniyfeeerlhkcn
hierarchy_sort_str	2019
callnumber-subject-code	RE
publishDate	2019
allfields	10.14744/bej.2019.52824 doi (DE-627)DOAJ004845854 (DE-599)DOAJ2b027a394f7c49cb9bbe4f8833cff692 DE-627 ger DE-627 rakwb eng RE1-994 Ufuk Urdem verfasserin aut Refractive Results and Endothelial Cell Density After Eyecryl Phakic Intraocular Lens Implantation 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier INTRODUCTION[\|]This study was an examination of the refractive results and complications encountered with implantation of the Eyecryl phakic intraocular lens (IOL) (Biotech Vision Care, Luzern, Switzerland).[¤]METHODS[\|]IOL recipients with a follow-up period of at least 2 years were included the study. Uncorrected and corrected distance visual acuity (UDVA and CDVA, respectively), central endothelial cell density (ECD), and procedure-related complication data were recorded.[¤]RESULTS[\|]The study included 52 eyes from 26 patients. The efficacy index (postoperative UDVA/preoperative CDVA) was 1.32+-1.09 in the first year and 1.39+-1.03 in the second year. The safety index (postoperative CDVA/preoperative CDVA) was 1.69+-1.16 at the last follow-up. None of the patients lost 2 or more lines of CDVA. The mean ECD loss was –4.51+-9.69% at 1 year (p=0.005). There was no statistically significant ECD loss between the 1- and 2-year follow-up visits (p=0.794).[¤]DISCUSSION AND CONCLUSION[\|]The results of Eyecryl phakic IOL implantation were favorable in terms of efficacy and safety.[¤] cataract endothelial cells phakic intraocular lenses postoperative complications visual acuity. Ophthalmology Alper Agca verfasserin aut In Beyoglu Eye Journal KARE Publishing, 2020 4(2019), 1, Seite 17-22 (DE-627)1725122200 25870394 nnns volume:4 year:2019 number:1 pages:17-22 https://doi.org/10.14744/bej.2019.52824 kostenfrei https://doaj.org/article/2b027a394f7c49cb9bbe4f8833cff692 kostenfrei https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-52824 kostenfrei https://doaj.org/toc/2587-0394 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 4 2019 1 17-22
spelling	10.14744/bej.2019.52824 doi (DE-627)DOAJ004845854 (DE-599)DOAJ2b027a394f7c49cb9bbe4f8833cff692 DE-627 ger DE-627 rakwb eng RE1-994 Ufuk Urdem verfasserin aut Refractive Results and Endothelial Cell Density After Eyecryl Phakic Intraocular Lens Implantation 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier INTRODUCTION[\|]This study was an examination of the refractive results and complications encountered with implantation of the Eyecryl phakic intraocular lens (IOL) (Biotech Vision Care, Luzern, Switzerland).[¤]METHODS[\|]IOL recipients with a follow-up period of at least 2 years were included the study. Uncorrected and corrected distance visual acuity (UDVA and CDVA, respectively), central endothelial cell density (ECD), and procedure-related complication data were recorded.[¤]RESULTS[\|]The study included 52 eyes from 26 patients. The efficacy index (postoperative UDVA/preoperative CDVA) was 1.32+-1.09 in the first year and 1.39+-1.03 in the second year. The safety index (postoperative CDVA/preoperative CDVA) was 1.69+-1.16 at the last follow-up. None of the patients lost 2 or more lines of CDVA. The mean ECD loss was –4.51+-9.69% at 1 year (p=0.005). There was no statistically significant ECD loss between the 1- and 2-year follow-up visits (p=0.794).[¤]DISCUSSION AND CONCLUSION[\|]The results of Eyecryl phakic IOL implantation were favorable in terms of efficacy and safety.[¤] cataract endothelial cells phakic intraocular lenses postoperative complications visual acuity. Ophthalmology Alper Agca verfasserin aut In Beyoglu Eye Journal KARE Publishing, 2020 4(2019), 1, Seite 17-22 (DE-627)1725122200 25870394 nnns volume:4 year:2019 number:1 pages:17-22 https://doi.org/10.14744/bej.2019.52824 kostenfrei https://doaj.org/article/2b027a394f7c49cb9bbe4f8833cff692 kostenfrei https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-52824 kostenfrei https://doaj.org/toc/2587-0394 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 4 2019 1 17-22
allfields_unstemmed	10.14744/bej.2019.52824 doi (DE-627)DOAJ004845854 (DE-599)DOAJ2b027a394f7c49cb9bbe4f8833cff692 DE-627 ger DE-627 rakwb eng RE1-994 Ufuk Urdem verfasserin aut Refractive Results and Endothelial Cell Density After Eyecryl Phakic Intraocular Lens Implantation 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier INTRODUCTION[\|]This study was an examination of the refractive results and complications encountered with implantation of the Eyecryl phakic intraocular lens (IOL) (Biotech Vision Care, Luzern, Switzerland).[¤]METHODS[\|]IOL recipients with a follow-up period of at least 2 years were included the study. Uncorrected and corrected distance visual acuity (UDVA and CDVA, respectively), central endothelial cell density (ECD), and procedure-related complication data were recorded.[¤]RESULTS[\|]The study included 52 eyes from 26 patients. The efficacy index (postoperative UDVA/preoperative CDVA) was 1.32+-1.09 in the first year and 1.39+-1.03 in the second year. The safety index (postoperative CDVA/preoperative CDVA) was 1.69+-1.16 at the last follow-up. None of the patients lost 2 or more lines of CDVA. The mean ECD loss was –4.51+-9.69% at 1 year (p=0.005). There was no statistically significant ECD loss between the 1- and 2-year follow-up visits (p=0.794).[¤]DISCUSSION AND CONCLUSION[\|]The results of Eyecryl phakic IOL implantation were favorable in terms of efficacy and safety.[¤] cataract endothelial cells phakic intraocular lenses postoperative complications visual acuity. Ophthalmology Alper Agca verfasserin aut In Beyoglu Eye Journal KARE Publishing, 2020 4(2019), 1, Seite 17-22 (DE-627)1725122200 25870394 nnns volume:4 year:2019 number:1 pages:17-22 https://doi.org/10.14744/bej.2019.52824 kostenfrei https://doaj.org/article/2b027a394f7c49cb9bbe4f8833cff692 kostenfrei https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-52824 kostenfrei https://doaj.org/toc/2587-0394 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 4 2019 1 17-22
allfieldsGer	10.14744/bej.2019.52824 doi (DE-627)DOAJ004845854 (DE-599)DOAJ2b027a394f7c49cb9bbe4f8833cff692 DE-627 ger DE-627 rakwb eng RE1-994 Ufuk Urdem verfasserin aut Refractive Results and Endothelial Cell Density After Eyecryl Phakic Intraocular Lens Implantation 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier INTRODUCTION[\|]This study was an examination of the refractive results and complications encountered with implantation of the Eyecryl phakic intraocular lens (IOL) (Biotech Vision Care, Luzern, Switzerland).[¤]METHODS[\|]IOL recipients with a follow-up period of at least 2 years were included the study. Uncorrected and corrected distance visual acuity (UDVA and CDVA, respectively), central endothelial cell density (ECD), and procedure-related complication data were recorded.[¤]RESULTS[\|]The study included 52 eyes from 26 patients. The efficacy index (postoperative UDVA/preoperative CDVA) was 1.32+-1.09 in the first year and 1.39+-1.03 in the second year. The safety index (postoperative CDVA/preoperative CDVA) was 1.69+-1.16 at the last follow-up. None of the patients lost 2 or more lines of CDVA. The mean ECD loss was –4.51+-9.69% at 1 year (p=0.005). There was no statistically significant ECD loss between the 1- and 2-year follow-up visits (p=0.794).[¤]DISCUSSION AND CONCLUSION[\|]The results of Eyecryl phakic IOL implantation were favorable in terms of efficacy and safety.[¤] cataract endothelial cells phakic intraocular lenses postoperative complications visual acuity. Ophthalmology Alper Agca verfasserin aut In Beyoglu Eye Journal KARE Publishing, 2020 4(2019), 1, Seite 17-22 (DE-627)1725122200 25870394 nnns volume:4 year:2019 number:1 pages:17-22 https://doi.org/10.14744/bej.2019.52824 kostenfrei https://doaj.org/article/2b027a394f7c49cb9bbe4f8833cff692 kostenfrei https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-52824 kostenfrei https://doaj.org/toc/2587-0394 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 4 2019 1 17-22
allfieldsSound	10.14744/bej.2019.52824 doi (DE-627)DOAJ004845854 (DE-599)DOAJ2b027a394f7c49cb9bbe4f8833cff692 DE-627 ger DE-627 rakwb eng RE1-994 Ufuk Urdem verfasserin aut Refractive Results and Endothelial Cell Density After Eyecryl Phakic Intraocular Lens Implantation 2019 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier INTRODUCTION[\|]This study was an examination of the refractive results and complications encountered with implantation of the Eyecryl phakic intraocular lens (IOL) (Biotech Vision Care, Luzern, Switzerland).[¤]METHODS[\|]IOL recipients with a follow-up period of at least 2 years were included the study. Uncorrected and corrected distance visual acuity (UDVA and CDVA, respectively), central endothelial cell density (ECD), and procedure-related complication data were recorded.[¤]RESULTS[\|]The study included 52 eyes from 26 patients. The efficacy index (postoperative UDVA/preoperative CDVA) was 1.32+-1.09 in the first year and 1.39+-1.03 in the second year. The safety index (postoperative CDVA/preoperative CDVA) was 1.69+-1.16 at the last follow-up. None of the patients lost 2 or more lines of CDVA. The mean ECD loss was –4.51+-9.69% at 1 year (p=0.005). There was no statistically significant ECD loss between the 1- and 2-year follow-up visits (p=0.794).[¤]DISCUSSION AND CONCLUSION[\|]The results of Eyecryl phakic IOL implantation were favorable in terms of efficacy and safety.[¤] cataract endothelial cells phakic intraocular lenses postoperative complications visual acuity. Ophthalmology Alper Agca verfasserin aut In Beyoglu Eye Journal KARE Publishing, 2020 4(2019), 1, Seite 17-22 (DE-627)1725122200 25870394 nnns volume:4 year:2019 number:1 pages:17-22 https://doi.org/10.14744/bej.2019.52824 kostenfrei https://doaj.org/article/2b027a394f7c49cb9bbe4f8833cff692 kostenfrei https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-52824 kostenfrei https://doaj.org/toc/2587-0394 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 4 2019 1 17-22
language	English
source	In Beyoglu Eye Journal 4(2019), 1, Seite 17-22 volume:4 year:2019 number:1 pages:17-22
sourceStr	In Beyoglu Eye Journal 4(2019), 1, Seite 17-22 volume:4 year:2019 number:1 pages:17-22
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	cataract endothelial cells phakic intraocular lenses postoperative complications visual acuity. Ophthalmology
isfreeaccess_bool	true
container_title	Beyoglu Eye Journal
authorswithroles_txt_mv	Ufuk Urdem @@aut@@ Alper Agca @@aut@@
publishDateDaySort_date	2019-01-01T00:00:00Z
hierarchy_top_id	1725122200
id	DOAJ004845854
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ004845854</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230310183716.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230225s2019 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.14744/bej.2019.52824</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ004845854</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ2b027a394f7c49cb9bbe4f8833cff692</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RE1-994</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Ufuk Urdem</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Refractive Results and Endothelial Cell Density After Eyecryl Phakic Intraocular Lens Implantation</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">INTRODUCTION[\|]This study was an examination of the refractive results and complications encountered with implantation of the Eyecryl phakic intraocular lens (IOL) (Biotech Vision Care, Luzern, Switzerland).[¤]METHODS[\|]IOL recipients with a follow-up period of at least 2 years were included the study. Uncorrected and corrected distance visual acuity (UDVA and CDVA, respectively), central endothelial cell density (ECD), and procedure-related complication data were recorded.[¤]RESULTS[\|]The study included 52 eyes from 26 patients. The efficacy index (postoperative UDVA/preoperative CDVA) was 1.32+-1.09 in the first year and 1.39+-1.03 in the second year. The safety index (postoperative CDVA/preoperative CDVA) was 1.69+-1.16 at the last follow-up. None of the patients lost 2 or more lines of CDVA. The mean ECD loss was –4.51+-9.69% at 1 year (p=0.005). There was no statistically significant ECD loss between the 1- and 2-year follow-up visits (p=0.794).[¤]DISCUSSION AND CONCLUSION[\|]The results of Eyecryl phakic IOL implantation were favorable in terms of efficacy and safety.[¤]</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">cataract</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">endothelial cells</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">phakic intraocular lenses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">postoperative complications</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">visual acuity.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Ophthalmology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Alper Agca</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Beyoglu Eye Journal</subfield><subfield code="d">KARE Publishing, 2020</subfield><subfield code="g">4(2019), 1, Seite 17-22</subfield><subfield code="w">(DE-627)1725122200</subfield><subfield code="x">25870394</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:4</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:17-22</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.14744/bej.2019.52824</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/2b027a394f7c49cb9bbe4f8833cff692</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-52824</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2587-0394</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">4</subfield><subfield code="j">2019</subfield><subfield code="e">1</subfield><subfield code="h">17-22</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	Ufuk Urdem
spellingShingle	Ufuk Urdem misc RE1-994 misc cataract misc endothelial cells misc phakic intraocular lenses misc postoperative complications misc visual acuity. misc Ophthalmology Refractive Results and Endothelial Cell Density After Eyecryl Phakic Intraocular Lens Implantation
authorStr	Ufuk Urdem
ppnlink_with_tag_str_mv	@@773@@(DE-627)1725122200
format	electronic Article
delete_txt_mv	keep
author_role	aut aut
collection	DOAJ
remote_str	true
callnumber-label	RE1-994
illustrated	Not Illustrated
issn	25870394
topic_title	RE1-994 Refractive Results and Endothelial Cell Density After Eyecryl Phakic Intraocular Lens Implantation cataract endothelial cells phakic intraocular lenses postoperative complications visual acuity
topic	misc RE1-994 misc cataract misc endothelial cells misc phakic intraocular lenses misc postoperative complications misc visual acuity. misc Ophthalmology
topic_unstemmed	misc RE1-994 misc cataract misc endothelial cells misc phakic intraocular lenses misc postoperative complications misc visual acuity. misc Ophthalmology
topic_browse	misc RE1-994 misc cataract misc endothelial cells misc phakic intraocular lenses misc postoperative complications misc visual acuity. misc Ophthalmology
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Beyoglu Eye Journal
hierarchy_parent_id	1725122200
hierarchy_top_title	Beyoglu Eye Journal
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)1725122200
title	Refractive Results and Endothelial Cell Density After Eyecryl Phakic Intraocular Lens Implantation
ctrlnum	(DE-627)DOAJ004845854 (DE-599)DOAJ2b027a394f7c49cb9bbe4f8833cff692
title_full	Refractive Results and Endothelial Cell Density After Eyecryl Phakic Intraocular Lens Implantation
author_sort	Ufuk Urdem
journal	Beyoglu Eye Journal
journalStr	Beyoglu Eye Journal
callnumber-first-code	R
lang_code	eng
isOA_bool	true
recordtype	marc
publishDateSort	2019
contenttype_str_mv	txt
container_start_page	17
author_browse	Ufuk Urdem Alper Agca
container_volume	4
class	RE1-994
format_se	Elektronische Aufsätze
author-letter	Ufuk Urdem
doi_str_mv	10.14744/bej.2019.52824
author2-role	verfasserin
title_sort	refractive results and endothelial cell density after eyecryl phakic intraocular lens implantation
callnumber	RE1-994
title_auth	Refractive Results and Endothelial Cell Density After Eyecryl Phakic Intraocular Lens Implantation
abstract	INTRODUCTION[\|]This study was an examination of the refractive results and complications encountered with implantation of the Eyecryl phakic intraocular lens (IOL) (Biotech Vision Care, Luzern, Switzerland).[¤]METHODS[\|]IOL recipients with a follow-up period of at least 2 years were included the study. Uncorrected and corrected distance visual acuity (UDVA and CDVA, respectively), central endothelial cell density (ECD), and procedure-related complication data were recorded.[¤]RESULTS[\|]The study included 52 eyes from 26 patients. The efficacy index (postoperative UDVA/preoperative CDVA) was 1.32+-1.09 in the first year and 1.39+-1.03 in the second year. The safety index (postoperative CDVA/preoperative CDVA) was 1.69+-1.16 at the last follow-up. None of the patients lost 2 or more lines of CDVA. The mean ECD loss was –4.51+-9.69% at 1 year (p=0.005). There was no statistically significant ECD loss between the 1- and 2-year follow-up visits (p=0.794).[¤]DISCUSSION AND CONCLUSION[\|]The results of Eyecryl phakic IOL implantation were favorable in terms of efficacy and safety.[¤]
abstractGer	INTRODUCTION[\|]This study was an examination of the refractive results and complications encountered with implantation of the Eyecryl phakic intraocular lens (IOL) (Biotech Vision Care, Luzern, Switzerland).[¤]METHODS[\|]IOL recipients with a follow-up period of at least 2 years were included the study. Uncorrected and corrected distance visual acuity (UDVA and CDVA, respectively), central endothelial cell density (ECD), and procedure-related complication data were recorded.[¤]RESULTS[\|]The study included 52 eyes from 26 patients. The efficacy index (postoperative UDVA/preoperative CDVA) was 1.32+-1.09 in the first year and 1.39+-1.03 in the second year. The safety index (postoperative CDVA/preoperative CDVA) was 1.69+-1.16 at the last follow-up. None of the patients lost 2 or more lines of CDVA. The mean ECD loss was –4.51+-9.69% at 1 year (p=0.005). There was no statistically significant ECD loss between the 1- and 2-year follow-up visits (p=0.794).[¤]DISCUSSION AND CONCLUSION[\|]The results of Eyecryl phakic IOL implantation were favorable in terms of efficacy and safety.[¤]
abstract_unstemmed	INTRODUCTION[\|]This study was an examination of the refractive results and complications encountered with implantation of the Eyecryl phakic intraocular lens (IOL) (Biotech Vision Care, Luzern, Switzerland).[¤]METHODS[\|]IOL recipients with a follow-up period of at least 2 years were included the study. Uncorrected and corrected distance visual acuity (UDVA and CDVA, respectively), central endothelial cell density (ECD), and procedure-related complication data were recorded.[¤]RESULTS[\|]The study included 52 eyes from 26 patients. The efficacy index (postoperative UDVA/preoperative CDVA) was 1.32+-1.09 in the first year and 1.39+-1.03 in the second year. The safety index (postoperative CDVA/preoperative CDVA) was 1.69+-1.16 at the last follow-up. None of the patients lost 2 or more lines of CDVA. The mean ECD loss was –4.51+-9.69% at 1 year (p=0.005). There was no statistically significant ECD loss between the 1- and 2-year follow-up visits (p=0.794).[¤]DISCUSSION AND CONCLUSION[\|]The results of Eyecryl phakic IOL implantation were favorable in terms of efficacy and safety.[¤]
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	1
title_short	Refractive Results and Endothelial Cell Density After Eyecryl Phakic Intraocular Lens Implantation
url	https://doi.org/10.14744/bej.2019.52824 https://doaj.org/article/2b027a394f7c49cb9bbe4f8833cff692 https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-52824 https://doaj.org/toc/2587-0394
remote_bool	true
author2	Alper Agca
author2Str	Alper Agca
ppnlink	1725122200
callnumber-subject	RE - Ophthalmology
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.14744/bej.2019.52824
callnumber-a	RE1-994
up_date	2024-07-04T01:22:00.480Z
_version_	1803609566590533632
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ004845854</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230310183716.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230225s2019 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.14744/bej.2019.52824</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ004845854</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ2b027a394f7c49cb9bbe4f8833cff692</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RE1-994</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Ufuk Urdem</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Refractive Results and Endothelial Cell Density After Eyecryl Phakic Intraocular Lens Implantation</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">INTRODUCTION[\|]This study was an examination of the refractive results and complications encountered with implantation of the Eyecryl phakic intraocular lens (IOL) (Biotech Vision Care, Luzern, Switzerland).[¤]METHODS[\|]IOL recipients with a follow-up period of at least 2 years were included the study. Uncorrected and corrected distance visual acuity (UDVA and CDVA, respectively), central endothelial cell density (ECD), and procedure-related complication data were recorded.[¤]RESULTS[\|]The study included 52 eyes from 26 patients. The efficacy index (postoperative UDVA/preoperative CDVA) was 1.32+-1.09 in the first year and 1.39+-1.03 in the second year. The safety index (postoperative CDVA/preoperative CDVA) was 1.69+-1.16 at the last follow-up. None of the patients lost 2 or more lines of CDVA. The mean ECD loss was –4.51+-9.69% at 1 year (p=0.005). There was no statistically significant ECD loss between the 1- and 2-year follow-up visits (p=0.794).[¤]DISCUSSION AND CONCLUSION[\|]The results of Eyecryl phakic IOL implantation were favorable in terms of efficacy and safety.[¤]</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">cataract</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">endothelial cells</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">phakic intraocular lenses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">postoperative complications</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">visual acuity.</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Ophthalmology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Alper Agca</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Beyoglu Eye Journal</subfield><subfield code="d">KARE Publishing, 2020</subfield><subfield code="g">4(2019), 1, Seite 17-22</subfield><subfield code="w">(DE-627)1725122200</subfield><subfield code="x">25870394</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:4</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:17-22</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.14744/bej.2019.52824</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/2b027a394f7c49cb9bbe4f8833cff692</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-52824</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2587-0394</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">4</subfield><subfield code="j">2019</subfield><subfield code="e">1</subfield><subfield code="h">17-22</subfield></datafield></record></collection>
score	7.399331

Nicht das Richtige dabei?

Schreiben Sie uns!

Refractive Results and Endothelial Cell Density After Eyecryl Phakic Intraocular Lens Implantation

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?